CA Stock MarketDetailed Quotes

SZLS StageZero Life Sciences Ltd

Watchlist
  • 0.040
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
4.94MMarket Cap-245P/E (TTM)

StageZero Life Sciences Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Total revenue
-32.96%521.92K
-6.74%745.49K
-20.53%793.31K
-41.07%778.52K
-25.12%3.8M
676.48K
16.82%799.4K
146.64%998.2K
-46.67%1.32M
22.07%5.07M
Operating revenue
-32.96%521.92K
-6.74%745.49K
-20.53%793.31K
-41.07%778.52K
-25.12%3.8M
--676.48K
16.82%799.4K
146.64%998.2K
-46.67%1.32M
22.07%5.07M
Cost of revenue
-48.40%221.38K
-12.71%577.08K
-38.05%671.75K
-68.48%429.07K
7.92%4.2M
1.09M
-18.12%661.08K
77.77%1.08M
45.89%1.36M
12.57%3.89M
Gross profit
-13.71%301.54K
21.75%168.41K
241.20%121.56K
967.59%349.45K
-134.29%-403.75K
-415.71K
212.44%138.32K
58.05%-86.09K
-102.61%-40.28K
69.29%1.18M
Operating expense
-62.32%616.73K
-39.21%929.15K
-50.92%942.31K
-36.92%1.64M
-20.17%7.43M
1.31M
-35.76%1.53M
-10.04%1.92M
47.50%2.6M
129.79%9.31M
Selling and administrative expenses
-61.91%569.49K
-36.37%909.42K
-50.22%859.07K
-37.51%1.5M
-19.10%6.65M
--1.36M
-25.14%1.43M
-8.65%1.73M
36.25%2.39M
122.91%8.22M
-Selling and marketing expense
--0
-124.77%-12.66K
-82.44%16.65K
-84.36%76.13K
-39.99%746.41K
--113.66K
-77.61%51.11K
-77.45%94.8K
--486.84K
--1.24M
-General and administrative expense
-59.87%569.49K
-33.09%922.08K
-48.35%842.43K
-25.54%1.42M
-15.37%5.91M
--1.25M
-18.02%1.38M
11.04%1.63M
8.53%1.91M
89.19%6.98M
Research and development costs
--0
-80.15%19.73K
-57.10%83.23K
-51.82%61.01K
-54.55%351.99K
---68.08K
-56.35%99.4K
171.44%194.03K
--126.63K
254.16%774.54K
Depreciation amortization depletion
111.91%18.28K
----
----
-6.43%8.63K
-6.71%35.81K
---123.02K
----
----
308.06%9.22K
29.41%38.39K
-Depreciation and amortization
111.91%18.28K
----
----
-6.43%8.63K
-6.71%35.81K
---123.02K
----
----
308.06%9.22K
29.41%38.39K
Other operating expenses
-59.81%28.96K
----
----
8.47%72.05K
43.07%390.5K
--142.81K
----
----
6,833.51%66.42K
140.10%272.95K
Operating profit
75.52%-315.19K
45.28%-760.73K
59.09%-820.75K
51.15%-1.29M
3.65%-7.83M
-1.73M
44.45%-1.39M
14.25%-2.01M
-1,121.99%-2.64M
-142.34%-8.13M
Net non-operating interest income (expenses)
70.86%-40.75K
61.27%-26.85K
-108.13%-99.88K
-223.77%-139.84K
-41.82%-284.07K
-123.63K
-4.16%-69.34K
3.37%-47.99K
32.06%-43.19K
69.85%-200.31K
Non-operating interest expense
-70.86%40.75K
-61.27%26.85K
108.13%99.88K
223.77%139.84K
9.44%219.21K
--58.77K
4.16%69.34K
-3.37%47.99K
-30.74%43.19K
-37.49%200.31K
Total other finance cost
----
----
----
----
--64.86K
----
----
----
----
----
Other net income (expenses)
92.35%-29.41K
-102.42%-34.29K
-32.78%519.09K
-118.42%-384.55K
-489.16%-3.3M
-7.65M
307.11%1.41M
-88.51%772.28K
129.76%2.09M
129.79%847.23K
Gain on sale of security
92.19%-29.41K
-103.05%-34.29K
--524.5K
-128.61%-376.37K
-17.39%2.27M
---249.83K
6.39%1.13M
----
123.78%1.32M
254.33%2.74M
Special income (charges)
----
--0
--0
----
-611.39%-5.53M
---7.36M
138.67%288.24K
386.10%772.28K
--772.28K
---777.51K
-Less:Restructuring and mergern&acquisition
----
--0
--0
----
-335.73%-1.83M
--0
-138.67%-288.24K
-386.10%-772.28K
---772.28K
--777.51K
-Less:Impairment of capital assets
----
----
----
----
--7.36M
----
----
----
----
--0
Other non-operating income (expenses)
----
----
---5.41K
---8.18K
97.14%-31.97K
---31.96K
-100.04%-12
----
----
-4.76%-1.12M
Income before tax
78.68%-386.35K
-1,722.52%-821.88K
68.67%-401.54K
-206.84%-1.81M
-52.53%-11.42M
-9.5M
97.97%-45.1K
-129.60%-1.28M
91.91%-590.5K
-9.03%-7.48M
Income tax
0
0
0
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
78.68%-386.35K
-1,722.52%-821.88K
68.67%-401.54K
-206.84%-1.81M
-52.53%-11.42M
-9.5M
97.97%-45.1K
-129.60%-1.28M
91.91%-590.5K
-9.03%-7.48M
Net income continuous operations
78.68%-386.35K
-1,722.52%-821.88K
68.67%-401.54K
-206.84%-1.81M
-52.53%-11.42M
---9.5M
97.97%-45.1K
-129.60%-1.28M
91.91%-590.5K
-9.03%-7.48M
Noncontrolling interests
Net income attributable to the company
78.68%-386.35K
-1,722.52%-821.88K
68.67%-401.54K
-206.84%-1.81M
-52.53%-11.42M
-9.5M
97.97%-45.1K
-129.60%-1.28M
91.91%-590.5K
-9.03%-7.48M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
78.68%-386.35K
-1,722.52%-821.88K
68.67%-401.54K
-206.84%-1.81M
-52.53%-11.42M
-9.5M
97.97%-45.1K
-129.60%-1.28M
91.91%-590.5K
-9.03%-7.48M
Diluted earnings per share
84.37%-0.0031
-2,152.25%-0.01
67.28%-0.0033
-100.00%-0.02
0.00%-0.11
-0.09
97.78%-0.0004
-120.00%-0.01
87.50%-0.01
26.67%-0.11
Basic earnings per share
84.37%-0.0031
-2,152.25%-0.01
67.28%-0.0033
-100.00%-0.02
0.00%-0.11
-0.09
97.78%-0.0004
-120.00%-0.01
87.50%-0.01
26.67%-0.11
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Total revenue -32.96%521.92K-6.74%745.49K-20.53%793.31K-41.07%778.52K-25.12%3.8M676.48K16.82%799.4K146.64%998.2K-46.67%1.32M22.07%5.07M
Operating revenue -32.96%521.92K-6.74%745.49K-20.53%793.31K-41.07%778.52K-25.12%3.8M--676.48K16.82%799.4K146.64%998.2K-46.67%1.32M22.07%5.07M
Cost of revenue -48.40%221.38K-12.71%577.08K-38.05%671.75K-68.48%429.07K7.92%4.2M1.09M-18.12%661.08K77.77%1.08M45.89%1.36M12.57%3.89M
Gross profit -13.71%301.54K21.75%168.41K241.20%121.56K967.59%349.45K-134.29%-403.75K-415.71K212.44%138.32K58.05%-86.09K-102.61%-40.28K69.29%1.18M
Operating expense -62.32%616.73K-39.21%929.15K-50.92%942.31K-36.92%1.64M-20.17%7.43M1.31M-35.76%1.53M-10.04%1.92M47.50%2.6M129.79%9.31M
Selling and administrative expenses -61.91%569.49K-36.37%909.42K-50.22%859.07K-37.51%1.5M-19.10%6.65M--1.36M-25.14%1.43M-8.65%1.73M36.25%2.39M122.91%8.22M
-Selling and marketing expense --0-124.77%-12.66K-82.44%16.65K-84.36%76.13K-39.99%746.41K--113.66K-77.61%51.11K-77.45%94.8K--486.84K--1.24M
-General and administrative expense -59.87%569.49K-33.09%922.08K-48.35%842.43K-25.54%1.42M-15.37%5.91M--1.25M-18.02%1.38M11.04%1.63M8.53%1.91M89.19%6.98M
Research and development costs --0-80.15%19.73K-57.10%83.23K-51.82%61.01K-54.55%351.99K---68.08K-56.35%99.4K171.44%194.03K--126.63K254.16%774.54K
Depreciation amortization depletion 111.91%18.28K---------6.43%8.63K-6.71%35.81K---123.02K--------308.06%9.22K29.41%38.39K
-Depreciation and amortization 111.91%18.28K---------6.43%8.63K-6.71%35.81K---123.02K--------308.06%9.22K29.41%38.39K
Other operating expenses -59.81%28.96K--------8.47%72.05K43.07%390.5K--142.81K--------6,833.51%66.42K140.10%272.95K
Operating profit 75.52%-315.19K45.28%-760.73K59.09%-820.75K51.15%-1.29M3.65%-7.83M-1.73M44.45%-1.39M14.25%-2.01M-1,121.99%-2.64M-142.34%-8.13M
Net non-operating interest income (expenses) 70.86%-40.75K61.27%-26.85K-108.13%-99.88K-223.77%-139.84K-41.82%-284.07K-123.63K-4.16%-69.34K3.37%-47.99K32.06%-43.19K69.85%-200.31K
Non-operating interest expense -70.86%40.75K-61.27%26.85K108.13%99.88K223.77%139.84K9.44%219.21K--58.77K4.16%69.34K-3.37%47.99K-30.74%43.19K-37.49%200.31K
Total other finance cost ------------------64.86K--------------------
Other net income (expenses) 92.35%-29.41K-102.42%-34.29K-32.78%519.09K-118.42%-384.55K-489.16%-3.3M-7.65M307.11%1.41M-88.51%772.28K129.76%2.09M129.79%847.23K
Gain on sale of security 92.19%-29.41K-103.05%-34.29K--524.5K-128.61%-376.37K-17.39%2.27M---249.83K6.39%1.13M----123.78%1.32M254.33%2.74M
Special income (charges) ------0--0-----611.39%-5.53M---7.36M138.67%288.24K386.10%772.28K--772.28K---777.51K
-Less:Restructuring and mergern&acquisition ------0--0-----335.73%-1.83M--0-138.67%-288.24K-386.10%-772.28K---772.28K--777.51K
-Less:Impairment of capital assets ------------------7.36M------------------0
Other non-operating income (expenses) -----------5.41K---8.18K97.14%-31.97K---31.96K-100.04%-12---------4.76%-1.12M
Income before tax 78.68%-386.35K-1,722.52%-821.88K68.67%-401.54K-206.84%-1.81M-52.53%-11.42M-9.5M97.97%-45.1K-129.60%-1.28M91.91%-590.5K-9.03%-7.48M
Income tax 0000000000
Earnings from equity interest net of tax
Net income 78.68%-386.35K-1,722.52%-821.88K68.67%-401.54K-206.84%-1.81M-52.53%-11.42M-9.5M97.97%-45.1K-129.60%-1.28M91.91%-590.5K-9.03%-7.48M
Net income continuous operations 78.68%-386.35K-1,722.52%-821.88K68.67%-401.54K-206.84%-1.81M-52.53%-11.42M---9.5M97.97%-45.1K-129.60%-1.28M91.91%-590.5K-9.03%-7.48M
Noncontrolling interests
Net income attributable to the company 78.68%-386.35K-1,722.52%-821.88K68.67%-401.54K-206.84%-1.81M-52.53%-11.42M-9.5M97.97%-45.1K-129.60%-1.28M91.91%-590.5K-9.03%-7.48M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 78.68%-386.35K-1,722.52%-821.88K68.67%-401.54K-206.84%-1.81M-52.53%-11.42M-9.5M97.97%-45.1K-129.60%-1.28M91.91%-590.5K-9.03%-7.48M
Diluted earnings per share 84.37%-0.0031-2,152.25%-0.0167.28%-0.0033-100.00%-0.020.00%-0.11-0.0997.78%-0.0004-120.00%-0.0187.50%-0.0126.67%-0.11
Basic earnings per share 84.37%-0.0031-2,152.25%-0.0167.28%-0.0033-100.00%-0.020.00%-0.11-0.0997.78%-0.0004-120.00%-0.0187.50%-0.0126.67%-0.11
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg